CPAP and measures of cardiovascular risk in males with OSAS.

CPAP and measures of cardiovascular risk in males with OSAS.

Obstructive sleep apnoea syndrome (OSAS) has been associated with hypertension, stroke and myocardial ischaemia in epidemiological and observational studies. Continuous positive airway pressure (CPAP) is the treatment of choice for OSAS, but the impact of this intervention on established risk factor...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Kohler, M, Pepperell, J, Casadei, B, Craig, S, Crosthwaite, N, Stradling, JR, Davies, R
Formato:	Journal article
Idioma:	English
Publicado em:	2008

Registros relacionados

Blood pressure change after treatment for obstructive sleep apnoea (OSA) with continuous positive airway pressure (CPAP)
por: Pepperell, J, et al.
Publicado em: (2000)

CPAP IMPROVES ENDOTHELIAL FUNCTION IN MINIMALLY SYMPTOMATIC OSA PATIENTS: RESULTS FROM THE MOSAIC TRIAL
por: Kohler, M, et al.
Publicado em: (2010)

In minimally symptomatic OSA what is the best test to measure CPAP response?
por: Turnbull, C, et al.
Publicado em: (2015)

Residual sleepiness in patients with OSA on CPAP.
por: Stradling, JR
Publicado em: (2009)

Patterns of CPAP usage in patients with minimally symptomatic OSA
por: Turnbull, C, et al.
Publicado em: (2015)

Cardiovascular Risk in Asymptomatic OSA
por: Kohler, M, et al.
Publicado em: (2009)

CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial.
por: Kohler, M, et al.
Publicado em: (2013)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
por: Tang, I, et al.
Publicado em: (2020)

THE PRIMARY RESULTS OF THE MOSAIC TRIAL: DOES CPAP FOR MINIMALLY SYMPTOMATIC OSA REDUCE DAYTIME SLEEPINESS OR CALCULATED VASCULAR RISK?
por: Craig, SE, et al.
Publicado em: (2010)

In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP
por: Turnbull, CD, et al.
Publicado em: (2016)

The effects of CPAP withdrawal in patients with OSA on hypoxia-induced markers
por: Turnbull, C, et al.
Publicado em: (2016)

Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.
por: Antoniades, C, et al.
Publicado em: (2016)

Relative accuracy of algorithm-based prescription of nasal CPAP in OSA.
por: Stradling, JR, et al.
Publicado em: (2004)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
por: John R Stradling, et al.
Publicado em: (2020-09-01)

A novel, simplified approach to starting nasal CPAP therapy in OSA.
por: Stradling, JR, et al.
Publicado em: (2004)

Baseline blood pressure and hypersomnolence predict bp fall with CPAP treatment of OSA
por: Robinson, G, et al.
Publicado em: (2007)

EFFECT OF CPAP TREATMENT FOR OSA ON VISUAL PROCESSING OF DEGRADED WORDS
por: Proudlove, K, et al.
Publicado em: (2012)

Blood pressure variability in OSA – data from four randomised-controlled CPAP-withdrawal trials
por: Lettau, F, et al.
Publicado em: (2017)

Effect of CPAP withdrawal on myocardial perfusion in OSA - a randomized controlled trial
por: Schwarz, E, et al.
Publicado em: (2016)

Can autonomic arousals and neural net EEG analysis predict daytime sleepiness and its response to nCPAP in OSA?
por: Bennett, L, et al.
Publicado em: (1997)

Effect of CPAP-withdrawal on blood pressure in OSA: data from three randomized-controlled trials
por: Schwarz, E, et al.
Publicado em: (2016)

Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial.
por: Craig, S, et al.
Publicado em: (2009)

COVID-19 related changes in outpatient CPAP set-up pathways for OSA are linked with decreased 30-day CPAP usage
por: Turnbull, CD, et al.
Publicado em: (2021)

Does either obesity or OSA severity influence the response of autotitrating CPAP machines in very obese subjects?
por: Turnbull, C, et al.
Publicado em: (2015)

Effects of Overnight Supplemental Oxygen on Morning Blood Pressure in a Randomized Controlled CPAP Withdrawal Trial in Patients with OSA
por: Petousi, N, et al.
Publicado em: (2018)

Effect of CPAP on depressive symptoms in OSA
por: Samy S. Eldahdouh, et al.
Publicado em: (2014-04-01)

Effect of CPAP on cardiac function in minimally symptomatic patients with OSA: results from a subset of the MOSAIC randomized trial
por: Craig, S, et al.
Publicado em: (2015)

CPAP increases bronchial reactivity in OSAS patients
por: P. Korczyski, et al.
Publicado em: (2008-06-01)

Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA
por: Craig, S, et al.
Publicado em: (2014)

CrossTalk proposal: Most of the cardiovascular consequences of OSA are due to increased sympathetic activity.
por: Kohler, M, et al.
Publicado em: (2012)

CrossTalk proposal: Most of the cardiovascular consequences of OSA are due to increased sympathetic activity
por: Kohler, M, et al.
Publicado em: (2012)

Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA).
por: Robinson, G, et al.
Publicado em: (2008)

Platelet activation is increased in obstructive sleep apnoea and does not fall with CPAP treatment
por: Robinson, G, et al.
Publicado em: (2002)

The interaction among OSA, CPAP, and medications in patients with comorbid OSA and cardiovascular/cerebrovascular disease: a randomized controlled trial
por: Miaochan Lao, et al.
Publicado em: (2022-03-01)

Metabolic Sydrome Prediction in Mild/Moderate OSA Patients - Anthropometric Measures and Abdominal Fat Estimations by MRI
por: Craig, SE, et al.
Publicado em: (2009)

EFFECT OF CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) ON DIURNAL SODIUM AND WATER-EXCRETION IN OBSTRUCTIVE SLEEP-APNEA (OSA)
por: Warley, A, et al.
Publicado em: (1987)

Oximetry derivatives in the assessment of OSA
por: Bennett, L, et al.
Publicado em: (1999)

OSA and hypertension: do we know all the answers?
por: Kohler, M, et al.
Publicado em: (2013)

Baroreflex sensitivity increases after 4 weeks of nasal continuous positive airway presure therapy in patients with obstructive sleep apnoea
por: Pepperell, J, et al.
Publicado em: (2001)

DIABETIC MACULAR OEDEMA (DME) AND OBSTRUCTIVE SLEEP APNOEA (OSA)-VISUAL IMPROVIEMENT POST CPAP THERAPY. PROOF OF PRINCIPLE STUDY
por: Mason, R, et al.
Publicado em: (2010)